Page last updated: 2024-09-04

ezetimibe and Aortic Stenosis

ezetimibe has been researched along with Aortic Stenosis in 49 studies

Research

Studies (49)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (24.49)	29.6817
2010's	35 (71.43)	24.3611
2020's	2 (4.08)	2.80

Authors

Authors	Studies
Bang, CN; Boman, K; Egstrup, K; Greve, AM; Kesäniemi, YA; Pedersen, TR; Ray, S; Wachtell, K	1
Bahlmann, E; Chambers, JB; Cramariuc, D; Einarsen, E; Gerdts, E; Midtbo, H	1
Bahlmann, E; Cramariuc, D; Einarsen, E; Gerdts, E; Mancusi, C; Midtbø, H; Rossebø, A; Willems, S	1
Bahlmann, E; Boman, K; De Simone, G; Gerdts, E; Gohlke-Bärwolf, C; Lønnebakken, MT; Rossebø, AB; Saeed, S	1
Cioffi, G; Cramariuc, D; Einarsen, E; Gerdts, E; Mancusi, C; Midtbø, HB; Thomassen, HK	1
Bang, CN; Boman, K; Devereux, RB; Egstrup, K; Greve, AM; Nienaber, C; Okin, PM; Ray, S; Rossebø, AB; Wachtell, K	1
Bang, CN; Best, P; Boman, K; Egstrup, K; Forman, JL; Greve, AM; Kesäniemi, YA; Pedersen, TR; Rajamannan, NM; Ray, S; Wachtell, K	1
Bang, CN; Boman, K; Eugen-Olsen, J; Forman, JL; Greve, AM; Hodges, GW; Jeppesen, JL; Kesäniemi, YA; Olsen, MH; Ray, S; Wachtell, K	1
Bang, CN; Dalsgaard, M; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Ray, S; Rossebø, AB; Wachtell, K	1
Gerdts, E; Gohlke-Bärwolf, C; Jander, N; Minners, J; Pedersen, TR; Ray, S; Wachtell, K	1
Bang, CN; Boman, K; Dalsgaard, M; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Ray, S; Rossebø, AB; Wachtell, K	1
Bang, CN; Boman, K; Cramariuc, D; Dalsgaard, M; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Nienaber, CA; Okin, PM; Ray, S; Rossebø, AB; Wachtell, K	1
Bahlmann, E; Boman, K; Chambers, JB; Gerdts, E; Gohlke-Bärwolf, C; Hochholzer, W; Jander, N; Kaufmann, BA; Minners, J; Neumann, FJ; Nienaber, CA; Pedersen, TR; Ray, S; Rossebo, A; Wachtell, K	1
Basta, N; Bolin, K; Busch-Sørensen, M; Egstrup, K; Emneus, M; Green, A; Iachina, M; Kent, C; Kesäniemi, YA; McNally, R; Pedersen, TR; Ramey, DR; Ray, S; Stavem, K; Willenheimer, R	1
Bang, CN; Berg, RM; Boman, K; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Nielsen, OW; Nienaber, CA; Okin, PM; Ray, S; Rossebø, AB; Wachtell, K	1
Cioffi, G; Cramariuc, D; Devereux, RB; Gerdts, E; Lønnebakken, MT; Pedersen, TR; Rogge, BP; Rossebø, AB	1
Bang, CN; Boman, K; Devereux, RB; Gohlke-Bärwolf, C; Greve, AM; La Cour, M; Okin, PM; Pedersen, T; Ray, S; Rossebø, A; Wachtell, K	1
Mahdavi-Fard, A; Nader, ND; Pourafkari, L	1
Dobrzynski, JM; Kostis, JB	1
Boman, K; Greve, AM; Kesäniemi, YA; Nielsen, OW; Nienaber, CA; Olsen, MH; Pedersen, TR; Sabbah, M; Sajadieh, A; Wachtell, K; Willenheimer, R	1
Bahlmann, E; Chambers, JB; Cramariuc, D; Gerdts, E; Gohlke-Baerwolf, C; Jander, N; Kuck, KH; Lønnebakken, MT; Minners, J; Nienaber, CA; Ray, S; Seifert, R	1
Baigent, C; Califf, R; Clare, R; Collins, R; Emberson, J; Landray, M; Peto, R	1
Curfman, GD; D'Agostino, RB; Drazen, JM; Morrissey, S; Ware, JH	1
Boman, K; Brudi, P; Chambers, JB; Egstrup, K; Gerdts, E; Gohlke-Bärwolf, C; Holme, I; Kesäniemi, YA; Malbecq, W; Nienaber, CA; Pedersen, TR; Ray, S; Rossebø, AB; Skjaerpe, T; Wachtell, K; Willenheimer, R	1
Fleming, TR	1
Pazianas, M	1
Farmer, JA	1
Colquhoun, D; Hamilton-Craig, I; Kostner, K; Woodhouse, S	1
Nissen, SE; Taylor, AJ	1
Chambers, JB; Viljoen, A; Wierzbicki, AS	1
Carabello, BA	1
Cramariuc, D; Gerdts, E; Rieck, AE; Tuseth, N; Wachtell, K	1
Cramariuc, D; Gerdts, E; Gohlke-Bärwolf, C; Lund, BP; Rieck, AE; Rossebø, AB	1
Flameng, W; Herijgers, P; Hermans, H; Herregods, MC; Holvoet, P; Meuris, B; Verbeken, E	1
Boman, K; Brudi, P; Egstrup, K; Gohlke-Baerwolf, C; Holme, I; Kesäniemi, YA; Malbecq, W; Pedersen, TR; Rossebø, AB; Wachtell, K; Willenheimer, R	1
Bahlmann, E; Chambers, J; Cramariuc, D; Eriksen, E; Gerdts, E; Gohlke-Baerwolf, C; Kuck, KH; Nienaber, CA; Ray, S; Wachtell, K	1
Drazen, JM; Wood, AJ	1
Boman, K; Brudi, P; Chambers, JB; Egstrup, K; Gerdts, E; Gohlke-Bärwolf, C; Holme, I; Kesäniemi, YA; Malbecq, W; Nienaber, C; Pedersen, TR; Ray, S; Rossebø, AB; Skjærpe, T; Wachtell, K; Willenheimer, R	1
Boman, K; Brudi, P; Chambers, JB; Egstrup, K; Gerdts, E; Gohlke-Bärwolf, C; Holme, I; Jander, N; Kesäniemi, YA; Malbecq, W; Minners, J; Neumann, FJ; Nienaber, CA; Pedersen, TR; Ray, S; Rossebø, A; Skjærpe, T; Wachtell, K; Willenheimer, R	1
Cioffi, G; Cramariuc, D; Dalsgaard, M; Davidsen, ES; de Simone, G; Egstrup, K; Gerdts, E	1
Boman, K; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Kesäniemi, YA; Køber, L; Nienaber, C; Ray, S; Rossebø, AB; Wachtell, K; Willenheimer, R	1
Boman, K; Devereux, RB; Gerdts, E; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Ray, S; Rossebø, AB; Wachtell, K; Willenheimer, R	1
Bang, CN; Boman, K; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Nienaber, CA; Ray, S; Rossebø, AB; Wachtell, K	1
Boman, K; Cramariuc, D; Gerdts, E; Gohlke-Bärwolf, C; Lønnebakken, MT; Rieck, ÅE; Rossebø, AB; Staal, EM	1
Bahlmann, E; Cioffi, G; Cramariuc, D; Gerdts, E; Gohlke-Bärwolf, C; Lønnebakken, MT; Ray, S; Rieck, AE	1
Allen, C; Boman, K; Chambers, J; Egstrup, K; Gerdts, E; Gohlke-Bärwolf, C; Holme, I; Kesäniemi, VA; Malbecq, W; Nienaber, C; Pedersen, TR; Ray, S; Rossebø, AB; Skjaerpe, T; Wachtell, K; Willenheimer, R	1
Padial, LR	1

Reviews

5 review(s) available for ezetimibe and Aortic Stenosis

Article	Year
Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study. Current problems in cardiology, 2013, Volume: 38, Issue:9 Topics: Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Azetidines; Calcinosis; Comorbidity; Disease Progression; Drug Therapy, Combination; Ezetimibe; Humans; Hypertension; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Simvastatin; Treatment Outcome	2013
Ezetimibe--an update. Drug and therapeutics bulletin, 2009, Volume: 47, Issue:8 Topics: Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Drug Combinations; Drug Costs; Ezetimibe; Ezetimibe, Simvastatin Drug Combination; Humans; Hyperlipoproteinemia Type II; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Simvastatin	2009
Aortic stenosis and lipids: does intervention work? Current opinion in cardiology, 2010, Volume: 25, Issue:4 Topics: Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Biomarkers, Pharmacological; Calcinosis; Disease Progression; Endothelium, Vascular; Ezetimibe; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Simvastatin; Stress, Physiological	2010
Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside. Current problems in cardiology, 2010, Volume: 35, Issue:6 Topics: Animals; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Azetidines; Calcinosis; Disease Progression; Endothelium, Vascular; Ezetimibe; Heart Valve Prosthesis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Oxidative Stress; Randomized Controlled Trials as Topic	2010
Ezetimibe plus simvastatin cardiovascular outcomes study program. Expert review of cardiovascular therapy, 2008, Volume: 6, Issue:1 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Aortic Valve Stenosis; Atherosclerosis; Azetidines; Disease Progression; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Kidney Failure, Chronic; Simvastatin; Treatment Outcome	2008

Trials

30 trial(s) available for ezetimibe and Aortic Stenosis

Article	Year
Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis. The American journal of cardiology, 2019, 12-01, Volume: 124, Issue:11 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Asymptomatic Diseases; Biomarkers; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Echocardiography, Doppler; Ezetimibe; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Lipoproteins, LDL; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Simvastatin; Time Factors; Treatment Outcome	2019
Higher Acceleration/Ejection Time Ratio Predicts Impaired Outcome in Aortic Valve Stenosis. Circulation. Cardiovascular imaging, 2021, Volume: 14, Issue:1 Topics: Aged; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Disease Progression; Double-Blind Method; Echocardiography; Ezetimibe; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Prognosis; Prospective Studies; Severity of Illness Index; Simvastatin; Stroke Volume; Treatment Outcome; Ventricular Function, Left	2021
Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis. Open heart, 2021, Volume: 8, Issue:2 Topics: Aged; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Double-Blind Method; Echocardiography, Doppler; Energy Metabolism; Europe; Ezetimibe; Follow-Up Studies; Humans; Middle Aged; Myocardium; Prognosis; Prospective Studies; Simvastatin; Stroke Volume; Survival Rate; Ventricular Function, Left	2021
Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis. Heart (British Cardiac Society), 2017, Volume: 103, Issue:18 Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Ezetimibe; Female; Germany; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Norway; Prognosis; Prospective Studies; Risk Factors; Simvastatin; Stroke Volume; Survival Rate; Sweden; Ventricular Function, Left	2017
Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis. Heart (British Cardiac Society), 2017, Volume: 103, Issue:20 Topics: Aged; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Echocardiography; Ezetimibe; Female; Humans; Male; Middle Aged; Risk Factors; Severity of Illness Index; Sex Factors; Simvastatin; Treatment Outcome	2017
Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events. Journal of the American Heart Association, 2017, Nov-27, Volume: 6, Issue:12 Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Asymptomatic Diseases; Blood Pressure; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Ezetimibe; Female; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Morbidity; Propensity Score; Simvastatin; Survival Rate; United States	2017
Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study). The American journal of cardiology, 2018, 03-15, Volume: 121, Issue:6 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Disease Progression; Double-Blind Method; Drug Combinations; Echocardiography, Doppler; Ezetimibe; Female; Humans; Male; Middle Aged; Simvastatin; Survival Rate; Treatment Outcome	2018
Effect of simvastatin and ezetimibe on suPAR levels and outcomes. Atherosclerosis, 2018, Volume: 272 Topics: Aged; Anticholesteremic Agents; Aorta; Aortic Valve Stenosis; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Constriction, Pathologic; Disease Progression; Ezetimibe; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Receptors, Urokinase Plasminogen Activator; Risk Factors; Simvastatin	2018
Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study. International journal of cardiology, 2013, Oct-03, Volume: 168, Issue:3 Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Atrial Fibrillation; Atrial Function, Left; Azetidines; Blood Flow Velocity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Electrocardiography; Ezetimibe; Female; Heart Atria; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prognosis; Simvastatin; Treatment Outcome	2013
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). The American journal of cardiology, 2014, Sep-01, Volume: 114, Issue:5 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Cause of Death; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Ezetimibe; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Factors; Simvastatin; Survival Rate	2014
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF. Heart (British Cardiac Society), 2014, Volume: 100, Issue:24 Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Blood Flow Velocity; Echocardiography; Ezetimibe; Female; Heart Failure; Humans; Male; Prospective Studies; ROC Curve; Simvastatin; Stroke Volume	2014
Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial. The American journal of cardiology, 2014, Nov-15, Volume: 114, Issue:10 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Europe; Ezetimibe; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Neoplasms; Registries; Retrospective Studies; Risk Assessment; Simvastatin; Survival Rate; Time Factors	2014
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study. International journal of cardiology, 2015, Feb-01, Volume: 180 Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Atrial Fibrillation; Azetidines; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Global Health; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Rest; Simvastatin; Survival Rate; Time Factors	2015
Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis. Circulation. Cardiovascular imaging, 2015, Volume: 8, Issue:11 Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Drug Therapy, Combination; Echocardiography; Ezetimibe; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Simvastatin	2015
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). The American journal of cardiology, 2015, Dec-15, Volume: 116, Issue:12 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Cataract; Cholesterol, LDL; Denmark; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Norway; Risk Factors; Simvastatin; Sweden; United Kingdom; United States	2015
Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS). Circulation, 2016, Aug-09, Volume: 134, Issue:6 Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Blood Pressure; Double-Blind Method; Ezetimibe; Follow-Up Studies; Humans; Hypertension; Middle Aged; Simvastatin	2016
Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications. European heart journal. Cardiovascular Imaging, 2017, Apr-01, Volume: 18, Issue:4 Topics: Aged; Aortic Valve; Aortic Valve Stenosis; Echocardiography; Ezetimibe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index; Simvastatin; Survival Rate; Time Factors; Treatment Outcome	2017
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. The New England journal of medicine, 2008, Sep-25, Volume: 359, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anticholesteremic Agents; Aortic Valve Stenosis; Aspartate Aminotransferases; Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Coronary Artery Bypass; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Kaplan-Meier Estimate; Male; Neoplasms; Simvastatin; Treatment Outcome	2008
The SEAS Trial. Current cardiology reports, 2010, Volume: 12, Issue:2 Topics: Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Cholesterol, LDL; Coronary Artery Disease; Disease Progression; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin	2010
Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy). The American journal of cardiology, 2010, May-15, Volume: 105, Issue:10 Topics: Aged; Aged, 80 and over; Angiography; Aortic Valve Stenosis; Azetidines; Body Mass Index; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Ezetimibe; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Logistic Models; Male; Middle Aged; Multivariate Analysis; Obesity; Probability; Prognosis; Risk Assessment; Severity of Illness Index; Simvastatin; Stroke Volume; Systole; Treatment Outcome	2010
Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial. The American journal of cardiology, 2010, Jun-15, Volume: 105, Issue:12 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Apolipoproteins B; Atherosclerosis; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography, Doppler; Ezetimibe; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prognosis; Simvastatin; Time Factors	2010
Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: a SEAS substudy. JACC. Cardiovascular imaging, 2010, Volume: 3, Issue:6 Topics: Aged; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Azetidines; Drug Therapy, Combination; Echocardiography, Doppler; Europe; Ezetimibe; Female; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Interpretation, Computer-Assisted; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recovery of Function; Reproducibility of Results; Severity of Illness Index; Simvastatin; Treatment Outcome; Ventricular Function, Left	2010
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study). The American journal of cardiology, 2010, Dec-01, Volume: 106, Issue:11 Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Azetidines; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Ezetimibe; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Simvastatin; Treatment Outcome	2010
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Circulation, 2011, Mar-01, Volume: 123, Issue:8 Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Disease Progression; Electrocardiography; Ezetimibe; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Prospective Studies; Retrospective Studies; Severity of Illness Index; Simvastatin; Stroke Volume; Treatment Outcome; Ventricular Function, Left	2011
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Circulation, 2012, Jan-17, Volume: 125, Issue:2 Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Azetidines; Cardiovascular Diseases; Drug Therapy, Combination; Electrocardiography; Ezetimibe; Female; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Prognosis; Simvastatin; Ventricular Dysfunction, Left	2012
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study. Journal of the American College of Cardiology, 2012, Mar-27, Volume: 59, Issue:13 Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Azetidines; Bundle-Branch Block; Death, Sudden, Cardiac; Electrocardiography; Ezetimibe; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Simvastatin	2012
Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. American heart journal, 2012, Volume: 163, Issue:4 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Atrial Fibrillation; Azetidines; Double-Blind Method; Ezetimibe; Female; Heart Ventricles; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Simvastatin; Stroke; Time Factors; Ultrasonography	2012
Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:1 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Antihypertensive Agents; Aortic Valve Stenosis; Azetidines; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Echocardiography; Ezetimibe; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Simvastatin	2012
Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial). Cardiovascular ultrasound, 2012, Nov-05, Volume: 10 Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Blood Pressure; Double-Blind Method; Ezetimibe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Risk Factors; Simvastatin; Stroke Volume; Ventricular Function, Left	2012
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. The American journal of cardiology, 2007, Apr-01, Volume: 99, Issue:7 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Blood Flow Velocity; Cholesterol, HDL; Cholesterol, LDL; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Europe; Ezetimibe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Simvastatin; Stroke Volume; Treatment Outcome; Triglycerides; Ventricular Function, Left	2007

Other Studies

14 other study(ies) available for ezetimibe and Aortic Stenosis

Article	Year
Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Stroke, 2014, Volume: 45, Issue:7 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Comorbidity; Coronary Artery Bypass; Ezetimibe; Female; Heart Valve Prosthesis Implantation; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multicenter Studies as Topic; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Severity of Illness Index; Simvastatin; Stroke	2014
Effects of Statins on the Development of Cataract-the Long Standing Debate. The American journal of cardiology, 2016, Feb-01, Volume: 117, Issue:3 Topics: Aortic Valve Stenosis; Cataract; Cholesterol, LDL; Ezetimibe; Female; Humans; Male; Simvastatin	2016
Prevention of Cataract by Statins. The American journal of cardiology, 2016, Apr-01, Volume: 117, Issue:7 Topics: Aortic Valve Stenosis; Cataract; Cholesterol, LDL; Ezetimibe; Female; Humans; Male; Simvastatin	2016
Ezetimibe revisited. The Medical letter on drugs and therapeutics, 2008, Aug-25, Volume: 50, Issue:1293 Topics: Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Clinical Trials as Topic; Drug Combinations; Endpoint Determination; Ezetimibe; Humans; Hypercholesterolemia; Simvastatin	2008
Analyses of cancer data from three ezetimibe trials. The New England journal of medicine, 2008, Sep-25, Volume: 359, Issue:13 Topics: Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Follow-Up Studies; Humans; Hypercholesterolemia; Incidence; Neoplasms; Randomized Controlled Trials as Topic; Risk; Simvastatin	2008
Ezetimibe and cancer--an uncertain association. The New England journal of medicine, 2008, Sep-25, Volume: 359, Issue:13 Topics: Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Drug Therapy, Combination; Ezetimibe; Humans; Incidence; Neoplasms; Randomized Controlled Trials as Topic; Risk; Simvastatin	2008
Identifying and addressing safety signals in clinical trials. The New England journal of medicine, 2008, Sep-25, Volume: 359, Issue:13 Topics: Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Disease Progression; Drug Therapy, Combination; Ezetimibe; Humans; Incidence; Neoplasms; Randomized Controlled Trials as Topic; Risk; Simvastatin	2008
Calcific aortic stenosis. The New England journal of medicine, 2009, Jan-01, Volume: 360, Issue:1 Topics: Animals; Anticholesteremic Agents; Aortic Valve Stenosis; Atherosclerosis; Azetidines; Calcinosis; Disease Progression; Ezetimibe; Humans; Models, Biological; Renal Insufficiency, Chronic; Simvastatin	2009
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial). Current atherosclerosis reports, 2009, Volume: 11, Issue:2 Topics: Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Drug Therapy, Combination; Ezetimibe; Humans; Hypolipidemic Agents; Lipids; Simvastatin	2009
At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy. Heart, lung & circulation, 2009, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Cholesterol; Drug Therapy, Combination; Endpoint Determination; Ezetimibe; Female; Humans; Lipoproteins, LDL; Male; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Simvastatin	2009
Preliminary observations from preliminary trial results: have we finally had enough? Circulation. Cardiovascular quality and outcomes, 2008, Volume: 1, Issue:1 Topics: Adult; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Cardiovascular Surgical Procedures; Ezetimibe; Heart Failure; Humans; Incidence; Neoplasms; Randomized Controlled Trials as Topic; Reperfusion Injury; Research Design; Simvastatin; Survival Analysis; Treatment Outcome	2008
Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy). Blood pressure, 2010, Volume: 19, Issue:3 Topics: Aortic Valve Stenosis; Azetidines; Biomarkers; Cardiomegaly; Cardiomyopathy, Hypertrophic; Ezetimibe; Female; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Simvastatin	2010
Don't mess with the DSMB. The New England journal of medicine, 2010, Jul-29, Volume: 363, Issue:5 Topics: Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Cardiovascular Diseases; Clinical Trials Data Monitoring Committees; Diabetes Mellitus, Type 2; Ezetimibe; Humans; Hypoglycemic Agents; Neoplasms; Rosiglitazone; Simvastatin; Thiazolidinediones; United States	2010
Left atrial systolic force in asymptomatic aortic stenosis. Echocardiography (Mount Kisco, N.Y.), 2011, Volume: 28, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Blood Pressure; Body Mass Index; Chi-Square Distribution; Echocardiography, Doppler; Ezetimibe; Female; Heart Atria; Heart Function Tests; Heart Rate; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Regression Analysis; Risk Factors; Simvastatin; Systole	2011